Attention-deficit hyperactivity disorder (ADHD), or hyperkinetic disorder (HKD), is increasingly discussed in the virtual arena and at major International and European congresses focusing on mental health and psychiatry.
Meeting of Minds is a scientific and educational meeting initiated, organised and funded by Takeda, with the objective of providing a forum for ADHD scientists and clinicians to discuss the latest scientific evidence and share best practice in the management of ADHD. Read more to find out what happened at Meeting of Minds XIII (9–25 November 2021).
There are a number of International and European congresses, such as the EUNETHYDIS International Conference on ADHD, the European College of Neuropsychopharmacology (ECNP) Congress, the European Congress of Psychiatry, the European Society for Child and Adolescent Psychiatry (ESCAP) International Congress, the World Congress on ADHD and the World Psychiatric Association (WPA) International Congress. To find out dates and locations visit the congress calendar.
Read reports from past congresses to learn more about the science of ADHD and how the disorder impacts the lives of patients, their families and the society.